Kanaph Therapeutics Approved for KOSDAQ Listing... Trading Begins on the 16th
Korea Exchange announced on the 12th that it has approved the initial listing of Kanaph Therapeutics on the KOSDAQ market.
Kanaph Therapeutics will be listed in the KOSDAQ market's Technology Growth Division, with the stock code 'A0082N0'. Trading of Kanaph Therapeutics shares will begin on the 16th.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Kanaph Therapeutics, a company engaged in research and development in the fields of natural science and engineering, recorded annual sales of 4,251 million won and an operating profit of 4,722 million won in 2024. The listing underwriter is Korea Investment & Securities.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.